Infection of human fibroblasts and HEp-2 cells with herpes simplex virus type 1 (HSV-1) produced a decrease in the intracellular levels of cyclic adenosine 5'-monophosphate (cAMP) and a concomitant increase in the cyclic guanosine 5'-monophosphate (cGMP) levels. In both cell cultures, changes in cyclic nucleotide levels were first observed at 6 h after viral inoculation and were maximal at 12 h. In human fibroblasts, the addition of theophylline, dibutyryl cAMP, or papaverine (cAMP-enhancing compounds) decreased significantly the yield of HSV-1, whereas the addition of insulin or dibutyryl cGMP (cGMP-enhancing compounds) increased the viral yield. In HEp-2 celLs, only theophylline decreased the yield of HSV-1, and the cGMP-enhancing compounds had no apparent effect. Cyclic nucleotide-enhancing compounds exhibited their effect only if added to either cell culture within the first 3 h after inoculation with HSV-1.
Current observations suggest that between recurrent episodes of herpes simplex virus (HSV) infection, the virus is present in the sensory ganglia in an apparently nonreplicating state (2-4, 27, 30) . Although such diverse stimuli as ultraviolet (UV) light, fever, menstruation, and emotional stress have been noted to exacerbate the eruption of herpetic lesions in humans, it is still uncertain whether a common mechanism might be involved in altering the virus-host equilibrium favoring viral production and the formation of recurrent lesions (19) . In this regard, the cyclic nucleotides, cyclic adenosine 5'-monophosphate (cAMP) and cyclic guanosine 5'-monophosphate (cGMP), merit consideration. Thus, it has been found with other virus-cell culture systems that the virus-induced properties of infected cells are mediated through changes in cyclic nucleotide levels and that experimental manipulation of cyclic nucleotide levels can affect viral expression (1, 15, 20, 33) .
To obtain some insight into the possible relation between cyclic nucleotides and HSV in the various types of virus-cell interactions, we first conducted the studies reported here in productively infected systems. Information obtained in such systems could also have a bearing on the inflammatory and immunological response to HSV type 1 (HSV-1) infection, since many of these responses are known to be influenced by cyclic nucleotides in other models (5) . For these experiments, cultures of human fibroblasts and HEp-2 cells were monitored at various times after inoculation with HSV-1 to determine the effect of viral infection on the intracellular levels of cAMP and cGMP. We also examined the possible effect of several cAMP-and cGMPenhancing compounds on HSV-1 yields in these cell cultures and the time kinetics of those compounds found to exhibit an effect on viral yield.
MATERIALS AND METHODS Cell cultures. HEp-2 cells, a serially propagated culture derived from a human cancer of the larynx, were obtained from Bernard Roizman, University of Chicago. Diploid human fibroblasts of embryonic lung origin, supplied by Richard Whitley, University of Alabama, were used in their eighth passage throughout the experiments. For uniformity purposes, titration of HSV-1 was performed in primary rabbit kidney cells. The cell culture medium consisted of minimal essential medium with Eagle balanced salt solution, penicillin (100 U/ml), streptomycin (100 ,Ag/ml), sodium bicarbonate (1 g/liter), and N-2-hydroxyethyl piperazine-N'-2-ethanesulfonic acid (25 mM; Sigma Chemical Co.). The growth medium contained 20% fetal bovine serum for human fibroblasts, 10% fetal bovine serum for the HEp-2 cells, and 10% calf serum for the rabbit kidney cells. Prior to experimental use, confluent monolayers of human fibroblasts and HEp-2 cells were maintained for 24 h in medium containing 1% fetal bovine serum and 0.5% calf serum, respectively, and subsequently kept in serum-free medium for approximately 36 h.
HSV. The F strain of HSV-1 was propagated in HEp-2 cells. Intracellular virus was harvested, aliquoted in tryptose phosphate broth, and stored at -70°C. Virus was plaque titered in rabbit kidney monolayers overlaid with 1.5% carboxymethylcellulose in culture medium without serum. After a 2-day incubation period at 37°C, the plaques were fixed with 10% acetate-buffered Formalin, stained with 1% crystal violet in 20% methanol, and counted. UV irradiation of HSV-1 was performed on 5-ml aliquots in a 60-mm glass petri dish by a General Electric G1528 UV bulb for 30 min at a distance of 17.5 cm. No infectious virus was detected when the UV-irradiated HSV-1 was inoculated into rabbit kidney cell cultures.
Chemicals. The following chemicals, obtained from Sigma Chemical Co., were used. (i) cAMP-enhancing compounds were: 1,3-dimethylxanthine (theophylline); N6-02-dibutyryl adenosine 3',5'-cyclic monophosphoric acid (db3',5'-cAMP); adenosine 3',5'-cyclic monophosphoric acid (3',5'-cAMP); 6,7-dimethoxy-1-veratryl-isoquinoline (papaverine); and caffeine. (ii) cGMP-enhancing compounds were: insulin; N6-02'-dibutyryl guanosine-3',5'-cyclic monophosphoric acid (db3',5'-cGMP); and guanosine 3',5'-cyclic monophosphoric acid (3',5'-cGMP). (iii) Control compounds were adenosine; adenosine monophosphoric acid (AMP); adenosine 2',3'-cyclic monophosphoric acid (2',3'-cAMP); guanosine; guanosine monophosphoric acid (GMP); guanosine 2',3'-cyclic monophosphoric acid (2',3'-cGMP); and butyric acid. Concentrations of the compounds tested are listed in Table 1 and are those found in preliminary experiments to be nontoxic to the cell cultures.
Assay of intracellular cAMP and cGMP levels. ume of 0.5 ml. For control cultures simultaneously inoculated with HSV-1, 0.5 ml of medium without the compounds was added. After 18 h of incubation, the virus-inoculated cultures, with or without cyclic nucleotide-enhancing compounds, were freeze-thawed three times, the cell debris was pelleted at 1,500 rpm for 15 min, and the virus was plaqued on rabbit kidney monolayers to determine the viral yield. An 18-h viral harvest coincides with the completion of one viral replication cycle (25) . A t test was used to evaluate the difference between the mean viral yields in the control cultures and cultures exposed to the compounds.
Time kinetics of the effect of cyclic nucleotideenhancing compounds on viral yield. To determine the optimal time at which the addition of previously found effective compounds influenced the yield of HSV-1, cultures were inoculated with an MOI of 0.1 PFU/cell, as described previously. After viral adsorption, 0.25 ml of culture medium was added to the virus-inoculated cells. At various time intervals thereafter, an additional 0.25 ml of medium containing cyclic nucleotide-enhancing compounds was added at the final optimal concentrations found to affect the yield of HSV-1. A similar volume of medium without the compounds was added to the virus-inoculated control cultures. Virus yields were determined 18 h after inoculation of the cultures.
RESULTS
Effect of HSV-1 on cyclic nucleotide levels in HEp-2 and human fibroblast cultures. The ratios of intracellular cyclic nucleotide levels in HEp-2 cells and human fibroblasts infected VOL. 18, 1977 on October 12, 2017 by guest http://iai.asm.org/ Downloaded from with various MOI (1 to 100 PFU/cell) of HSV-1, as compared with mock-inoculated cell cultures, were determined at various times of incubation. The most consistent results were obtained with an MOI of 50 PFU/cell. In both HEp-2 cells and human fibroblasts, inoculation with HSV-1 produced a decrease in the cAMP levels and a coinciding increase in the cGMP levels (Fig. 1) . Differences in cyclic nucleotide levels between infected and noninfected cells cultures were first noted at 6 after incubation, were maximal at 12 h, and leveled off thereafter. Inoculation of the cell cultures with UV-irradiated HSV-1 did not affect the cAMP or cGMP levels. No differences were found in either cell counts or protein content between infected and uninfected cultures for the first 18 Table 2 . In human fibroblasts, the addition of theophylline, db3',5'-cAMP, or papaverine (cAMP-enhancing compounds) decreased significantly the yield of HSV-1, whereas the addition of insulin or db3',5'-cGMP (cGMP-enhancing compounds) increased the viral yields. In HEp-2 cells, only theophylline decreased the yield of HSV-1, and the cGMP-enhancing compounds had no apparent effect. There were no observable differences in the type or extent of viral cytopathic effect between control cultures and cultures exposed to those cyclic nucleotide-enhancing compounds affecting the yield of HSV-1 at 18 h after inoculation or in separate experiments in which incubation was continued for up to 48 h.
Experiments were also performed to control for other experimental variables that might have affected the results observed. When HSV was Infection of human fibroblasts or HEp-2 cells with HSV-1 was found to decrease the intracellular levels of cAMP and to increase cGMP levels ( Fig. 1) . In most virus-transformation or abortive-infection systems, a decrease in cAMP levels has also been noted (1, 15, 20, 21, 31 Our findings also indicate that cAMP-enhancing compounds decreased the yields of HSV-1 and cGMP-enhancing compounds increased viral yields in human fibroblasts. In other viruscell culture systems, the addition of cAMP-enhancing compounds was found to decrease or The similarity in the kinetics of cyclic nucleotide changes after HSV-1 inoculation in both HEp-2 cells, which are of neoplastic origin, and human fibroblasts, a diploid cell culture, is of interest in view of the variability in the replication of HSV in different cell cultures (12, 25) . On the other hand, the yield of HSV-1 in infected human fibroblasts was susceptible to a wider range of cyclic nucleotide-enhancing compounds than that in HEp-2 cells, in which only theophylline effectively decreased the virus yield (Table 2 ). This variation in specificity for cyclic nucleotide-enhancing compounds among various cell culture systems is not uncommon and could reflect the degree to which these compounds are adsorbed into a particular cell (13, 16) . Roizman (22, 23) has demonstrated an effect on HSV adsorption and penetration with thyroid and parathyroid hormones. Costa et al. (7) have also shown that glucocorticoids, which might affect cells through cyclic nucleotide pathways, had different effects on the virus yield of HSV-2 in vitro depending on cell type. Our findings could also be explained alternatively if the virusgene products were more effectively expressed in HEp-2 cells than in human fibroblasts and consequently less susceptible to alteration by the compounds. In this respect, Burk (6) Other biochemical events were not monitored concomitantly with the levels of cyclic nucleotides in this study, so any attempt to correlate cyclic nucleotides with herpesvirus replication would be speculative and must await further experimentation. Nevertheless, extrapolation of available data on HSV-1 replication in infected HEp-2 cells (24, 28, 29) would suggest that the initial changes in cyclic nucleotide levels occur when polyribosomes reach maximal levels, the rate of protein synthesis is maximal, and virions appear within the cell. Apparently the alteration in cyclic nucleotide levels requires the expression of a part of the viral genome that is sensitive to UV irradiation. A dose-response curve relating the degree of viral inactivation to changes in cyclic nucleotide levels was not performed; therefore, it is not possible to determine the extent to which the effective viral gene must be irradiated to reduce its action. Also, the changes in cyclic nucleotide levels that might occur due to transformation by UV-inactivated HSV require further experimentation (8, 18) .
The data presented here indicate that a relationship exists between cyclic nucleotides and HSV-1 in productively infected cells. What this relationship might be in vivo requires further experimentation in particular regard to issues related to inflammatory and immune responses to the viral infection and to HSV latency. Thus, cyclic nucleotides are known to play an important role in the regulation of inflammation and immunity (5) , and it has been shown (10) that HSV-induced leukocyte interferon releases histamine from basophils, which may affect cyclic nucleotides. Based on mouse studies, Hill and Blyth (9) recently proposed a regulatory effect of cyclic nucleotides on HSV latency. Presently, cultures of human ganglia latently infected with HSV are being examined for a possible regulatory phenomenon of cyclic nucleotides that hopefully may provide an insight into the mechanisms involved in the reactivation of HSV and a possible means for controlling endogenous herpetic recurrences.
